{"entity":{"type":"insider","cik":"0001968317","url":"/insider/0001968317","json_url":"/insider/0001968317.json","name":"Prasad Raju","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":8,"first":"2024-03-18","last":"2026-03-24","span_basis":"filed_date"},"name_variants":[{"name":"Prasad Raju","source":"filing","n_filings":8,"first_seen":"2024-03-18","last_seen":"2026-03-24"}],"transactions":[{"id":5847433,"accession":"0001193125-26-122268","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-122268","line_url":"/filing/0001193125-26-122268#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001968317","owner_name":"Prasad Raju","owner_url":"/insider/0001968317","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3708.0,"shares_display":"3,708","price_per_share":46.78,"price_display":"46.78","price_state":"stated","total_value":173460.24,"total_display":"173,460.24","shares_owned_after":15565.0,"shares_owned_after_display":"15,565","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-23","filed_date":"2026-03-24","scope":"insider"},{"id":6001638,"accession":"0001193125-26-111284","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193125-26-111284","line_url":"/filing/0001193125-26-111284#line-5","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001968317","owner_name":"Prasad Raju","owner_url":"/insider/0001968317","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5848.0,"shares_display":"5,848","price_per_share":48.26,"price_display":"48.26","price_state":"stated","total_value":282224.48,"total_display":"282,224.48","shares_owned_after":17794.0,"shares_owned_after_display":"17,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-17","scope":"insider"},{"id":6001634,"accession":"0001193125-26-111284","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-111284","line_url":"/filing/0001193125-26-111284#line-4","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001968317","owner_name":"Prasad Raju","owner_url":"/insider/0001968317","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4021.0,"shares_display":"4,021","price_per_share":48.26,"price_display":"48.26","price_state":"stated","total_value":194053.46,"total_display":"194,053.46","shares_owned_after":13773.0,"shares_owned_after_display":"13,773","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-17","scope":"insider"},{"id":5846804,"accession":"0001193125-26-022845","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-022845","line_url":"/filing/0001193125-26-022845#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001968317","owner_name":"Prasad Raju","owner_url":"/insider/0001968317","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34972.0,"shares_display":"34,972","price_per_share":60.19,"price_display":"60.19","price_state":"stated","total_value":2104964.68,"total_display":"2,104,964.68","shares_owned_after":6767.0,"shares_owned_after_display":"6,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-26","scope":"insider"},{"id":6152210,"accession":"0001193125-26-007875","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193125-26-007875","line_url":"/filing/0001193125-26-007875#line-5","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001968317","owner_name":"Prasad Raju","owner_url":"/insider/0001968317","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18933.0,"shares_display":"18,933","price_per_share":60.1799,"price_display":"60.18","price_state":"stated","total_value":1139386.0467,"total_display":"1,139,386.05","shares_owned_after":17534.0,"shares_owned_after_display":"17,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-08","scope":"insider"},{"id":6152207,"accession":"0001193125-26-007875","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-007875","line_url":"/filing/0001193125-26-007875#line-4","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001968317","owner_name":"Prasad Raju","owner_url":"/insider/0001968317","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5763.0,"shares_display":"5,763","price_per_share":60.2134,"price_display":"60.21","price_state":"stated","total_value":347009.8242,"total_display":"347,009.82","shares_owned_after":6767.0,"shares_owned_after_display":"6,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-08","scope":"insider"},{"id":6152205,"accession":"0001193125-26-007875","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-007875","line_url":"/filing/0001193125-26-007875#line-3","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001968317","owner_name":"Prasad Raju","owner_url":"/insider/0001968317","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5004.0,"shares_display":"5,004","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":300240.0,"total_display":"300,240.00","shares_owned_after":12530.0,"shares_owned_after_display":"12,530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-08","scope":"insider"},{"id":4673261,"accession":"0001193125-25-331162","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-25-331162","line_url":"/filing/0001193125-25-331162#line-3","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001968317","owner_name":"Prasad Raju","owner_url":"/insider/0001968317","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5472.0,"shares_display":"5,472","price_per_share":56.3345,"price_display":"56.33","price_state":"stated","total_value":308262.384,"total_display":"308,262.38","shares_owned_after":7767.0,"shares_owned_after_display":"7,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-22","filed_date":"2025-12-23","scope":"insider"},{"id":4673260,"accession":"0001193125-25-331162","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-331162","line_url":"/filing/0001193125-25-331162#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001968317","owner_name":"Prasad Raju","owner_url":"/insider/0001968317","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3528.0,"shares_display":"3,528","price_per_share":55.1022,"price_display":"55.10","price_state":"stated","total_value":194400.5616,"total_display":"194,400.56","shares_owned_after":13239.0,"shares_owned_after_display":"13,239","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-22","filed_date":"2025-12-23","scope":"insider"},{"id":4673259,"accession":"0001193125-25-331162","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-331162","line_url":"/filing/0001193125-25-331162#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001968317","owner_name":"Prasad Raju","owner_url":"/insider/0001968317","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":56.8858,"price_display":"56.89","price_state":"stated","total_value":56885.8,"total_display":"56,885.80","shares_owned_after":6767.0,"shares_owned_after_display":"6,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-22","filed_date":"2025-12-23","scope":"insider"},{"id":4164767,"accession":"0000950170-25-043973","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-043973","line_url":"/filing/0000950170-25-043973#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001968317","owner_name":"Prasad Raju","owner_url":"/insider/0001968317","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2197.0,"shares_display":"2,197","price_per_share":41.23,"price_display":"41.23","price_state":"stated","total_value":90582.31,"total_display":"90,582.31","shares_owned_after":16767.0,"shares_owned_after_display":"16,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-21","filed_date":"2025-03-24","scope":"insider"},{"id":4131626,"accession":"0000950170-25-041471","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-041471","line_url":"/filing/0000950170-25-041471#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001968317","owner_name":"Prasad Raju","owner_url":"/insider/0001968317","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3762.0,"shares_display":"3,762","price_per_share":41.8,"price_display":"41.80","price_state":"stated","total_value":157251.6,"total_display":"157,251.60","shares_owned_after":12714.0,"shares_owned_after_display":"12,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-18","scope":"insider"},{"id":2587464,"accession":"0000950170-24-032990","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-032990","line_url":"/filing/0000950170-24-032990#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001968317","owner_name":"Prasad Raju","owner_url":"/insider/0001968317","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3524.0,"shares_display":"3,524","price_per_share":72.69,"price_display":"72.69","price_state":"stated","total_value":256159.56,"total_display":"256,159.56","shares_owned_after":6476.0,"shares_owned_after_display":"6,476","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-15","filed_date":"2024-03-18","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001674416","name":"CRISPR Therapeutics AG","url":"/issuer/0001674416","role":"Officer (Chief Financial Officer)","n_filings":8,"first_seen":"2024-03-18","last_seen":"2026-03-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001968317","retrieved_at":"2026-08-21T17:02:53+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}